Sol-Gel Technologies

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLGL and other ETFs, options, and stocks.

About SLGL

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T.

CEO

Alon Seri-Levy

CEOAlon Seri-Levy

Employees

Employees36

Headquarters

Ness Ziona, Tel Aviv

HeadquartersNess Ziona, Tel Aviv

Founded

1997

Founded1997

Employees

Employees36

SLGL Key Statistics

Market cap

23.74M

Market cap23.74M

Price-Earnings ratio

-0.84

Price-Earnings ratio-0.84

Dividend yield

—

Dividend yield—

Average volume

24.70K

Average volume24.70K

High today

$0.8898

High today$0.8898

Low today

$0.7125

Low today$0.7125

Open price

$0.7125

Open price$0.7125

Volume

24.49K

Volume24.49K

52 Week high

$4.05

52 Week high$4.05

52 Week low

$0.682

52 Week low$0.682

Sol-Gel Technologies

Why Robinhood?

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. Show more

SLGL Key Statistics

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T.